Highly potent active pharmaceutical ingredients (HPAPIs) now account for a major portion of the drug development pipeline, thanks to benefits including innovative therapeutic potential, reduced side effects, and high specificity. However, their potency poses risks to manufacturing personnel throughout the bench to commercial scale-up process. To ensure safety during HPAPI production, manufacturers must have the knowledge to effectively use containment and design high-quality equipment. As drug companies seek the most compatible HPAPI manufacturing partner to meet their goals, it is critical to understand the offerings synonymous with ample experience and safety expertise to ensure efficient timelines.

Fill out the form to download the white paper >>>